Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
Tóm tắt
Từ khóa
Tài liệu tham khảo
Foti, 1977, Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase, New Engl. J. Med., 297, 1357, 10.1056/NEJM197712222972501
Griffiths, 1980, Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease, Clin. Chem., 26, 433, 10.1093/clinchem/26.3.433
Bruce, 1981, The significance of prostatic acid phosphatase in adenocarcinoma of the prostate, J. Urol., 125, 357, 10.1016/S0022-5347(17)55036-3
Vihko, 1981, Effective ness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy on prostatic carcinoma, Cancer Res., 41, 1180
Wang, 1979, Purification of a human prostate specific antigen, Invest. Urol., 17, 159
Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate, Monogr. Urol., 10, 49
Hara, 1971, Some physico-chemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma, Jap. J. Legal Med., 25, 322
Li, 1973, Isolation and characterization of two specific antigens of human seminal plasma, Fertil. Steril., 24, 134, 10.1016/S0015-0282(16)39496-1
Sensabaugh, 1978, Isolation and characterization of a semen-specific protein from human seminal plasma: a potential new marker for semen identification, J. Forensic Sci., 23, 106, 10.1520/JFS10659J
Graves, 1985, Postcoital detection of male-specific semen protein. Application to the investigation of rape, New Engl. J. Med., 312, 338, 10.1056/NEJM198502073120603
Wang, 1982, A simplified purification procedure for human prostate antigen, Oncology, 39, 1, 10.1159/000225594
Papsidero, 1980, A prostate antigen in sera of prostatic cancer patients, Cancer Res., 40, 2428
Kuriyama, 1980, Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay, Cancer Res., 40, 4658
Wang, 1981, Prostate antigen: a new potential marker for prostatic cancer, Prostate, 2, 89, 10.1002/pros.2990020109
Chu, 1989, Prostate-specific antigenic domain of human prostate-specific antigen identified with monoclonal antibodies, J. Urol., 141, 152, 10.1016/S0022-5347(17)40630-6
Watt, 1986, Human prostate-specific antigen: structural and functional similarity with serine proteases, Proc. Natl. Acad. Sci., 83, 3166, 10.1073/pnas.83.10.3166
Wang, 1982, Prostate antigen of human cancer patients, 179
Riegman, 1989, Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene, Biochem. Biophys. Res. Comm., 159, 95, 10.1016/0006-291X(89)92409-1
Schedlich, 1987, Primary structure of a human glandular kallikrein gene, DNA, 6, 429, 10.1089/dna.1987.6.429
Lundwall, 1987, Molecular cloning of human prostate specific antigen with cDNA, FEBS Letters, 214, 317, 10.1016/0014-5793(87)80078-9
Riegman, 1988, Molecular cloning and characterization of novel prostate antigen with cDNA’s, Biochem. Biophys. Res. Comm., 155, 181, 10.1016/S0006-291X(88)81066-0
Lilja, 1985, A kallikrein-like serine protease in prostatic fluid leaves the predominant seminal vesicle protein, J. Clin. Invest., 76, 1899, 10.1172/JCI112185
Papsidero, 1981, Prostate antigen: a marker for human prostate epithelial cells, J. Natl. Cancer Inst., 66, 37
Nadji, 1981, Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms, Cancer, 48, 1229, 10.1002/1097-0142(19810901)48:5<1229::AID-CNCR2820480529>3.0.CO;2-L
Mancini, 1965, Immunochemical quantitation of antigens by single radioimmunodiffusion, Immunochemistry, 2, 235, 10.1016/0019-2791(65)90004-2
Lilja, 1985, The predominant protein in human seminal coagulate, Scand. J. Clin. Lab. Invest., 45, 635, 10.3109/00365518509155271
Herr, 1986, Characterization of a monoclonal antibody to a conserved epitope on human seminal vesicle specific peptides: a novel probe/marker system for semen identification, Biol. Reprod., 35, 773, 10.1095/biolreprod35.3.773
Evans, 1986, Immunohistochemical localization of the MHS-5 antigen in principal cells of human seminal vesicle epithelium, Anat. Rec., 214, 372, 10.1002/ar.1092140406
McGee, 1988, Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30), Biol. Reprod., 39, 499, 10.1095/biolreprod39.2.499
Akiyama, 1987, The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein, FEBS Letters, 225, 168, 10.1016/0014-5793(87)81151-1
Ban, 1984, The proteolytic activity of human prostate-specific antigen, Biochem. Biophys. Res. Comm., 123, 482, 10.1016/0006-291X(84)90256-0
Dubé, 1986, Dog prostate arginine esterase is related to human prostate specific antigen, Clin. Invest. Med., 9, 51
Lee, 1989, Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia, Urology, 34, 4
Lee, 1989, Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen, Radiology, 170, 29, 10.1148/radiology.170.1.2462262
Lee, 1988, Prostate cancer: comparison of transrectal US and digital rectal examination for screening, Radiology, 168, 389, 10.1148/radiology.168.2.3293108
Stamey, 1987, Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate, New Engl. J. Med., 317, 909, 10.1056/NEJM198710083171501
Graves, 1990, Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard, J. Urol., 144, 1516, 10.1016/S0022-5347(17)39789-6
Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients, J. Urol., 141, 1076, 10.1016/S0022-5347(17)41175-X
Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients, J. Urol., 141, 1070, 10.1016/S0022-5347(17)41174-8
Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients, J. Urol., 141, 1084, 10.1016/S0022-5347(17)41176-1
Kabalin, 1989, Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen, J. Urol., 142, 326, 10.1016/S0022-5347(17)38746-3
Kuriyama, 1981, Use of human prostate-specific antigen in monitoring prostate cancer, Cancer Res., 41, 3874
Yalow, 1971, Introduction and general considerations, 1
Yang, 1989, a double antibody radioimmunoassay for prostate-specific antigen, 172
Yang, 1989, PSA values in BPH and stage A prostate cancer, 197
Killian, 1985, Investigators of the National Prostatic Cancer Project: Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer, Cancer Res., 45, 886
Oesterling, 1988, Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy, J. Urol., 139, 766, 10.1016/S0022-5347(17)42630-9
Dejter, 1988, Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation, Urology, 32, 288, 10.1016/0090-4295(88)90228-2
Maatman, 1989, The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate, J. Urol., 141, 1378, 10.1016/S0022-5347(17)41313-9
Schifman, 1987, Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared, Clin. Chem., 33, 2086, 10.1093/clinchem/33.11.2086
Brawer, 1988, The effect of digital rectal examination on serum levels of prostate-specific antigen, Arch. Path. Lab. Med., 112, 1110
Hughes, 1987, Serum prostatic specific antigen: in vitro stability and the effect of ultrasound rectal examination in vivo, Ann. Clin. Biochem., 24, 206
Lindstedt, 1990, Determination of prostate-specific antigen in serum by immunoradiometric assay, Clin. Chem., 36, 53, 10.1093/clinchem/36.1.53
Armitage, 1988, The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer, Brit. J. Urol., 62, 584, 10.1111/j.1464-410X.1988.tb04431.x
Seamonds, 1986, Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers, Urology, 28, 472, 10.1016/0090-4295(86)90146-9
Myrtle, 1986, Clinical utility of prostate-specific antigen (PSA) in the management of prostate cancer
Myrtle, 1989, Normal levels of prostate-specific antigen (PSA), 183
Ercole, 1987, Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer, J. Urol., 138, 1181, 10.1016/S0022-5347(17)43543-9
Rock, 1987, Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen, Clin. Chem., 33, 2257, 10.1093/clinchem/33.12.2257
Chan, 1987, Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared, Clin. Chem., 33, 1916, 10.1093/clinchem/33.10.1916
Hortin, 1988, Differences in values obtained with 2 assays of prostate specific antigen, J. Urol., 139, 762, 10.1016/S0022-5347(17)42627-9
Ryall, 1982, Reappraisal of the causes of the “hook effect” in two-site immunoradiometric assays, Anal. Biochem., 127, 308, 10.1016/0003-2697(82)90178-6
Vaidya, 1988, Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the “hook effect.”, Clin. Chem., 34, 2175, 10.1093/clinchem/34.10.2175
Alfthan, 1988, Falsely low results obtained with the Hybritech Tandem-R PSA assay, Clin. Chem., 34, 2152, 10.1093/clinchem/34.10.2152
Boder, 1989, More on “hook effects” in immunometric assays for prostate-specific antigen, Clin. Chem., 35, 1262, 10.1093/clinchem/35.6.1262
Liedtke, 1984, Measurement of prostate-specific antigen by radioimmunoassay, Clin. Chem., 30, 649, 10.1093/clinchem/30.5.649
Myrtle, J. F.: Personal communication.
Bruce, 1987, Tumor markers in prostatic disease, 196
Hudson, 1989, Clinical use of prostate specific antigen in patients with prostate cancer, J. Urol., 142, 1011, 10.1016/S0022-5347(17)38972-3
Ferro, 1987, Tumour markers in prostatic carcinoma: a comparison of prostate-specific antigen with acid phosphatase, Brit. J. Urol., 60, 69, 10.1111/j.1464-410X.1987.tb09137.x
Weber, 1989, The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia, J. Urol., 141, 987, 10.1016/S0022-5347(17)41083-4
Partin, 1990, Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia, J. Urol., 143, 747, 10.1016/S0022-5347(17)40079-6
McNeal, 1986, Intraductal dysplasia: a premalignant lesion of the prostate, Hum. Path., 17, 64, 10.1016/S0046-8177(86)80156-3
Bostwick, 1989, Prostatic intraepithelial neoplasia (PIN), Urology, 34, 16
McNeal, 1988, Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia, Amer. J. Clin. Path., 89, 41, 10.1093/ajcp/89.1.41
McNeal, 1988, Immunohistochemical evidence of impaired cell differentiation in the premalignant phase of prostate carcinogenesis, Amer. J. Clin. Path., 90, 23, 10.1093/ajcp/90.1.23
Nagle, 1989, Immunophenotypic study of prostatic hyperplasia (BPH), dysplasia (PD), and carcinoma (CA), Lab. Invest., 60, 65A
Perlmen, 1989, Blood group antigen expression in dysplasia and adenocarcinoma of the prostate, Lab. Invest., 60, 72A
Brawer, 1989, Prostatic intraepithelial neoplasia and prostate-specific antigen, Urology, 34, 62
Brawer, M. K., Rennels, M. A., Nagle, R. B., Schifman, R. A. and Gaines, J. A.: Significance of serum prostate-specific antigen in men undergoing prostate surgery for benign disease. Amer. J. Clin. Path., in press.
Lange, 1989, The value of serum prostate specific antigen determinations before and after radical prostatectomy, J. Urol., 141, 873, 10.1016/S0022-5347(17)41037-8
Chu, 1987, What’s new in tumor markers for prostate cancer?, Urology, 27, 487
Walsh, 1986, Benign prostatic hyperplasia, vol. 2, 1248
Cooner, 1990, Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen, J. Urol., 143, 1146, 10.1016/S0022-5347(17)40211-4
Brawer, 1989, Prostate-specific antigen:, its role in early detection, staging, and monitoring of prostatic carcinoma, J. Endourol., 3, 227, 10.1089/end.1989.3.227
Chybowski, 1991, Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters, J. Urol., 145, 313, 10.1016/S0022-5347(17)38325-8
Silverberg, 1990, Cancer statistics 1990, CA, 40, 1
Zincke, H.: Personal communication.
Carter, 1989, The use of prostate-specific antigen in the management of patients with prostate cancer: The Johns Hopkins experience, 247
Morgan, 1991, Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation), J. Urol., 145, 319, 10.1016/S0022-5347(17)38327-1
Lightner, 1989, PSA response to radiation therapy (RT) after radical prostatectomy (RP), J. Urol., 141, 183A
Stamey, 1989, Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients, J. Urol., 141, 1088, 10.1016/S0022-5347(17)41177-3
Lightner, D. J., Lange, P. H., Ercole, C. J., Unger, K., Sauers, J. B., Mathisen, M. L. and Vessella, R. L.: Serum prostatic-specific antigen (PSA) and the utility of isotopic bone scan (BOS) in the monitoring of patients with carcinoma of the prostate (CAP). Proc. Amer. Ass. Clin. Oncol., abstract 461, 1988.
Bilhartz, D. L., Young, C. Y. F., Flanagan, W. F., He, W. and Tindall, D. J.: Expression of prostate-specific antigen (PSA) in LNCaP cells in culture. Read at Molecular and Cellular Biology of Prostate Cancer Meeting, Prouts Neck, Maine, October 1989.
Csapo, 1988, Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice, J. Urol., 140, 1032, 10.1016/S0022-5347(17)41921-5
Leo, 1991, Prostate-specific antigen in hormonally treated D2 prostate cancer: is it always an accurate indicator of disease status?, J. Urol., 145, 802, 10.1016/S0022-5347(17)38456-2
Stein, 1982, Immunoperoxidase localization of prostate-specific antigen, Amer. J. Surg. Path., 6, 553, 10.1097/00000478-198209000-00007
Vernon, 1983, Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostate specific antigen, J. Urol., 130, 95, 10.1016/S0022-5347(17)50977-5
Allhoff, 1983, Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer, J. Urol., 129, 315, 10.1016/S0022-5347(17)52074-1
Ghazizadeh, 1984, Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen, Urol. Int., 39, 9, 10.1159/000280934
Purnell, 1984, Immunocyto-chemical evaluation of human prostatic carcinomas for carcino-embryonic antigen, nonspecific cross-reacting antigen, B chorionic gonadotrophin, and prostate-specific antigen, Cancer Res., 44, 285
Epstein, 1984, Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate, Hum. Path., 15, 853, 10.1016/S0046-8177(84)80146-X
Ford, 1985, Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice, Brit. J. Urol., 57, 50, 10.1111/j.1464-410X.1985.tb08984.x
Svanholm, 1988, Clinical application of prostatic markers. I. Classification of prostatic tumors using immunohistochemical techniques. Scand, J. Urol. Nephrol., 107, 65
Brawer, 1989, Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates, Cancer, 63, 454, 10.1002/1097-0142(19890201)63:3<454::AID-CNCR2820630311>3.0.CO;2-E
Jöbsis, 1978, Demonstration of the prostatic origin of metastases, Cancer, 41, 1788, 10.1002/1097-0142(197805)41:5<1788::AID-CNCR2820410521>3.0.CO;2-D
Jöbsis, 1981, The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry, Histochem. J., 13, 961, 10.1007/BF01002636
Li, 1980, Immunohistochemical diagnosis of prostatic cancer with metastasis, Cancer, 46, 706, 10.1002/1097-0142(19800815)46:4<706::AID-CNCR2820460412>3.0.CO;2-E
Nadji, 1980, Prostatic origin of tumors. An immunohistochemical study, Amer. J. Clin. Path., 73, 735, 10.1093/ajcp/73.6.735
Sobin, 1986, Prostatic acid phosphatase activity in carcinoid tumors, Cancer, 58, 136, 10.1002/1097-0142(19860701)58:1<136::AID-CNCR2820580124>3.0.CO;2-S
Svanholm, 1986, Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase, Acta Path. Microbiol. Immunol. Scand., sect. A, 94, 7